GeneDx Holdings Corp (NASDAQ: WGS) on Monday, plunged -8.26% from the previous trading day, before settling in for the closing price of $102.85. Within the past 52 weeks, WGS’s price has moved between $7.59 and $115.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 16.51% over the last five years. The company achieved an average annual earnings per share of 248.68%. With a float of $24.45 million, this company’s outstanding shares have now reached $28.02 million.
The firm has a total of 1000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 60.75%, operating margin of -7.24%, and the pretax margin is -17.22%.
GeneDx Holdings Corp (WGS) Breakdown of a Key Holders of the stock
Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of GeneDx Holdings Corp is 12.89%, while institutional ownership is 86.43%. The most recent insider transaction that took place on Mar 03 ’25, was worth 27,100. Before that another transaction happened on Feb 24 ’25, when Company’s Stockholder proposed sale 373,569 for $95.83, making the entire transaction worth $35,799,117.
GeneDx Holdings Corp (WGS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 248.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 119.03% during the next five years compared to 96.65% growth over the previous five years of trading.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
GeneDx Holdings Corp (WGS) is currently performing well based on its current performance indicators. A quick ratio of 3.42 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.99, a number that is poised to hit 0.08 in the next quarter and is forecasted to reach 1.89 in one year’s time.
Technical Analysis of GeneDx Holdings Corp (WGS)
Analysing the last 5-days average volume posted by the [GeneDx Holdings Corp, WGS], we can find that recorded value of 1.06 million was lower than the volume posted last year of 1.23 million. As of the previous 9 days, the stock’s Stochastic %D was 47.39%. Additionally, its Average True Range was 9.54.
During the past 100 days, GeneDx Holdings Corp’s (WGS) raw stochastic average was set at 68.12%, which indicates a significant increase from 57.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 178.05% in the past 14 days, which was higher than the 117.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $81.27, while its 200-day Moving Average is $53.50. Now, the first resistance to watch is $102.72. This is followed by the second major resistance level at $111.09. The third major resistance level sits at $115.45. If the price goes on to break the first support level at $89.99, it is likely to go to the next support level at $85.63. Now, if the price goes above the second support level, the third support stands at $77.26.
GeneDx Holdings Corp (NASDAQ: WGS) Key Stats
Market capitalization of the company is 2.65 billion based on 28,068K outstanding shares. Right now, sales total 305,450 K and income totals -52,290 K. The company made 95,640 K in profit during its latest quarter, and 5,440 K in sales during its previous quarter.
